Thus collectively, our results demonstrate that inhibition of GFAT or OGT combined with low-dose chemotherapy treatment induces a switch of colon cancer cells from senescence to apoptosis associated with an enhancement of DNA damage. The gene discussed is GFPT2; the disease is colonic neoplasm.